Prothena reported $51.85M in Operating Expenses for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Acadia Pharmaceuticals ACAD:US USD 161.58M 6.63M
Agios Pharmaceuticals AGIO:US USD 90.16M 10.35M
Akebia Therapeutics AKBA:US USD 98.04M 5.19M
ALKERMES ALKS:US USD 313M 2.32M
Alnylam Pharmaceuticals ALNY:US USD 598.93M 182.43M
Amgen AMGN:US USD 4.61B 695M
Biogen BIIB:US USD 1.19B 1.45B
Biomarin Pharmaceutical BMRN:US USD 507.76M 13.12M
Bluebird Bio BLUE:US USD 84.85M 24.07M
Exelixis EXEL:US USD 329.12M 6.6M
Intercept Pharmaceuticals ICPT:US USD 179.49M 94.37M
Intra Cellular Therapies ITCI:US USD 127.5M 16M
IONIS PHARMACEUT IONS:US USD 218.92M 384K
Macrogenics MGNX:US USD 66.69M 1.13M
Nektar Therapeutics NKTR:US USD 77.93M 96.49M
Neurocrine Biosciences NBIX:US USD 300.1M 93.4M
Prothena PRTA:US USD 51.85M 7.33M
Regeneron Pharmaceuticals REGN:US USD 1.71B 34.8M
Seattle Genetics SGEN:US USD 703.1M 72.49M
Ultragenyx Pharmaceutical RARE:US USD 315.77M 84.83M
Vertex Pharmaceuticals VRTX:US USD 1.21B 117.7M
Vital Therapies VTL:US USD 20.12M 494K
Xoma XOMA:US USD 4.82M 927K
YTE INCY:US USD 684.93M 27.96M